A novel monoclonal antibody specific for the N-terminal end of GAD65

Journal of Neuroimmunology

Volumn 113, Issue 1, 2001, Pages 63-71

  Hampe, Christiane S ^a   Lundgren, Per ^a   Daniels, Terri L ^a   Hammerle, Lisa P ^a   Marcovina, Santica M ^a   Lernmark, Åke ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Autoimmunity; GAD67; Immunoglobulin; Polymerase chain reaction; Type 1 diabetes

Indexed keywords

COMPLEMENTARY DNA; GLUTAMATE DECARBOXYLASE; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SEQUENCE ANALYSIS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BLOTTING, WESTERN; DIABETES MELLITUS, TYPE 1; DNA, COMPLEMENTARY; GLUTAMATE DECARBOXYLASE; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0035255070     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00423-9     Document Type: Article

References (50)

1. Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures
2. Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase
3. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
4. Rodent islet antigens recognized by antibodies in sera from diabetic patients
5. A multiplicity of protein antigens in subcellular fractions of rat insulinoma tissue are able to stimulate T cells obtained from non-obese diabetic mice
6. Genetic isolation of the Lyp region on chromosome 4 in the diabetes prone BioBreeding (BB) rat
7. Prediction of IDDM in the general population: Strategies based on combinations of autoantibody markers
8. GAD autoantibodies in IDDM, Stiff-Man Syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes
9. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene
10. Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase
11. 2-terminal domain
12. Cleft palate in mice with a targeted mutation in the gamma-aminobutyric acid-producing enzyme glutamic acid decarboxylase 67
13. Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target difference epitopes
14. Immunohistochemical localization of glutamate decarboxylase in the rat oviduct and ovary: Further evidence for non-neural GABA system
15. Two genes encode distinct glutamate decarboxylase
16. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms
17. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies epitopes in childhood IDDM
18. 3H recombinant human ligands
19. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM
20. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD-64) showed 64K autoantibody positivity at onset predicts diabetes type
21. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10
22. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase
23. Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase
24. Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions
25. Glutamic acid decarboxylase - Gene to antigen to disease
26. Differential detection of rat islet and brain glutamic acid decarboxylase (GAD) isoforms with sequence-specific peptide antibodies
27. Production of monoclonal antibodies specific to theophylline-treated lymphocytes
28. Regulatory properties of brain glutamate decarboxylase (GAD): The apoenzyme of GAD is present principally as the smaller of two molecular forms of GAD in brain
29. Radioimmunoprecipitation assay for glutamic acid decarboxylase antibodies evaluated clinically with sera from patients with insulin-dependent diabetes mellitus
30. High concentration of GABA and high glutamate decarboxylase activity in rat pancreatic islets and human insulinoma
31. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction
32. Expression of the neurotransmitter-synthesizing enzyme glutamic acid decarboxylase in male germ cells
33. Analysis of GAD65 autoantibodies in NOD mice and GAD expression in the pancreas: Evidence for low antibody frequency and low expression
34. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen
35. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase
36. High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase
37. Heteromers of glutamate decarboxylase isoforms occur in rat cerebellum
38. Autoimmunity to glutamic acid decarboxylase (GAD) in Stiff Man syndrome and insulin-dependent diabetes mellitus
39. Glutamate decarboxylases in nonneural cells of rat testis and oviduct: Differential expression of GAD65 and GAD67
40. Phage display and bacterial expression of a recombinant Fab specific for Pseudomonas aeruginosa serotype O6 lipopolysaccharide
41. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: A comparison with those present in Type 1 diabetes
42. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes
43. Coordinate expression of antibody subunit genes yields high levels of functional antibodies in roots of transgenic tobacco
44. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. The Belgian Diabetes Registry
45. Absence of autoantibodies against glutamate decarboxylase in the NOD mouse and low expression of GAD65 in mouse islets; differences between the animal model and human Type 1 diabetes
46. Human autoantibodies react with glutamic acid decarboxylase antigen in human and rat but not in mouse pancreatic islets
47. Monoclonal antibodies specific to the glutamic acid decarboxylase 65 kDa isoform derived from a non-obese diabetic (NOD) mouse
48. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with Type 1 diabetes mellitus and stiff-man syndrome
49. A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes